Global generative AI in the personalized medicine market
DUBLIN, Feb. 28, 2024 (Globe Newswire) — The Generative AI in Personalized Medicine Market – Global Industry Size, Share, Trends, Opportunities, and Forecasts, 2018-2028 report has been added. ResearchAndMarkets.com Recruitment.
Global Generation of Personalized Medicine Markets AI is transforming the healthcare landscape, ushering in an era in which healthcare is intricately tailored to an individual’s genetic profile. In this comprehensive analysis, this fast-growing market was valued at USD 152.12 Million in 2022 and is projected to chart a strong growth trajectory at a CAGR of 25.62% till 2028. The integration of generative AI will revolutionize drug development, treatment plan optimization, and disease trend prediction, thereby creating a new standard in healthcare delivery.
North America leads in strategic advancements in generated AI healthcare applications
The North American region has established itself as a market leader primarily due to its advanced technological infrastructure, significant investments in healthcare, and strategic partnerships between technology giants and healthcare providers. This collaboration will be critical to harnessing the vast potential of generative AI and will make great strides in delivering personalized healthcare solutions to complex disease challenges.
Pharmaceuticals dominate personalized medicine as AI accelerates drug discovery
Pharmaceuticals are emerging as a major segment in the field of personalized medicine. The significant impact Generative AI is having on streamlining pharmaceutical pipelines is evident in its ability to rapidly analyze complex data, identify target molecules, and simulate drug interactions, reducing associated costs. significantly accelerate the drug discovery process while reducing and increasing the accuracy of therapeutic solutions.
Cloud-based deployment model facilitates scalable and efficient generative AI solutions
Cloud-based deployment models have become the preferred infrastructure for generative AI applications as organizations seek optimized compute power and scalability to process a wide range of healthcare data. This model provides the flexibility and efficiency needed to process and analyze the large-scale data essential to advancing personalized medicine.
Comprehensive regional analysis highlights the growth of personalized medicine around the world
The report provides detailed insights into the regional dynamics of the global Generative AI in Personalized Medicine market, highlighting the growth, opportunities, and challenges across North America, Europe, Asia Pacific, South America, and Middle East & Africa. Regional efforts to accelerate the integration of generative AI into personalized medicine are a testament to the global commitment to improving healthcare standards.
Multi-omics data integration and decentralized clinical trials: pioneering trends in personalized medicine
A key trend identified in the report is the progressive integration of multi-omics data, which enables multi-layered analyzes of genetic information that are essential for making finely tailored therapeutic interventions. Additionally, the rise of decentralized clinical trials is emerging as a transformative trend, employing generative AI to enhance the efficiency and effectiveness of drug development and patient monitoring.
End-user insights for hospitals, clinics, and surgery centers that accelerate the adoption of personalized medicine
Hospitals, clinics, and ambulatory surgery centers are recognized as important end users of global generative AI in the personalized medicine market. These healthcare organizations are at the forefront of implementing AI-powered personalized medicine, leveraging predictive analytics and personalized treatment protocols to deliver enhanced patient care.
-
Insights into the treatment of personalized medicine: A comprehensive survey of the pharmaceutical, genomic medicine, and medical device fields in personalized medicine.
-
Deployment Model Insights: A deep dive into on-premises and cloud-based deployment models that are driving market expansion.
-
Regional Insights: Extensive investigation of market performance across North America, Europe, Asia Pacific, South America, and Middle East & Africa.
These insights and report details enable stakeholders to navigate the promising landscape of global generative AI in the personalized medicine market and identify strategic opportunities to drive growth and innovation in personalized medicine solutions. .
Key market drivers and challenges outlining the evolving personalized medicine landscape
Rising prevalence of complex diseases and breakthroughs in genomic research are driving the market forward. At the same time, challenges such as data interoperability and privacy concerns highlight the need for a careful and strategic approach when leveraging generative AI in the sensitive field of healthcare. As global generative AI in the personalized medicine market continues its impressive growth, healthcare is moving closer to a future where each patient’s treatment is as unique as her DNA, realizing the promise of truly personalized care. Masu.
key attributes
|
report attributes |
detail |
|
number of pages |
181 |
|
Forecast period |
2022-2028 |
|
Estimated market value in 2022 (USD) |
$152.12 million |
|
Projected market value to 2028 (USD) |
$591.9 million |
|
compound annual growth rate |
25.6% |
|
Target area |
global |
Some of the companies mentioned in this report include:
-
Syntegra
-
Nioya Tech
-
saxon
-
IBM Watson
-
microsoft
-
Google LLC
-
Tencent Holdings Co., Ltd.
-
Neuralink Co., Ltd.
-
johnson & johnson
-
OpenAI
-
oracle
For more information on this report, please visit https://www.researchandmarkets.com/r/p8tkan.
About ResearchAndMarkets.com
ResearchAndMarkets.com is the world’s leading source of international market research reports and market data. We provide the latest data on international and regional markets, key industries, top companies, new products and latest trends.
attachment
CONTACT: CONTACT: ResearchAndMarkets.com Laura Wood,Senior Press Manager press@researchandmarkets.com For E.S.T Office Hours Call 1-917-300-0470 For U.S./ CAN Toll Free Call 1-800-526-8630 For GMT Office Hours Call +353-1-416-8900
